Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
QuintilesIMS
Moodys
Accenture
Medtronic

Generated: August 24, 2019

DrugPatentWatch Database Preview

Interferon alfa-2b - Biologic Drug Details

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for interferon alfa-2b
Pharmacology for interferon alfa-2b

US Patents for interferon alfa-2b

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up IDENIX PHARMACEUTICALS LLC (Cambridge, MA) 2038-10-10 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Cipla Limited (Mumbia, IN) 2035-12-09 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for interferon alfa-2b

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
17/1999 Austria ➤ Sign Up PRODUCT NAME: INTERFERON ALFACON-1
20/1995 Austria ➤ Sign Up PRODUCT NAME: OCTOCOG ALFA
03C/024 Belgium ➤ Sign Up PRODUCT NAME: ENFUVIRTIDE; NAT. REGISTRATION NO/DATE: EU/1/03/252/001 20030527; FIRST REGISTRATION: CH 56282 20030430
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
Daiichi Sankyo
AstraZeneca
US Department of Justice
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.